The HTRF pro IL-1β detection kit is designed for the simple and rapid quantification of soluble pro IL-1β proteins in cell/tissue lysates.
| Feature | Specification |
|---|---|
| Application | Protein Quantification |
| Dynamic Range | 312.5 - 20,000 pg/mL |
| Limit of Detection | 38.5 pg/mL |
| Limit of Quantification | 130 pg/mL |
| Sample Volume | 16 µL |
The HTRF pro IL-1β detection kit is designed for the simple and rapid quantification of soluble pro IL-1β proteins in cell/tissue lysates.
Loading...
Pro IL-1β, also known as IL-1β precursor, is a 31 kDa protein precursor of IL-1β. It is produced in response to molecular motifs carried by pathogens called ‘pathogen associated molecular patterns’ (PAMPs). Induction of pro IL-1β expression is referred to as a priming step and is an inefficient secretion stimulus. The processing and cleavage of pro IL-1β into active IL-1β is conditioned by the activation stage involving PAMP, or DAMP (danger associated molecular pattern, endogenous molecules released from dead cells).
Pro IL-1β is cleaved by the pro-inflammatory protease caspase-1, activated via recruitment to a multi-protein complex termed the inflammasome.
The HTRF pro IL-1β assay is based on a TR-FRET sandwich immunoassay involving two specific antibodies, one labeled with Eu3+-cryptate (donor) and the other with d2 (acceptor). One antibody is directed against the IL-1β, and the second recognizes specifically pro IL-1β. When both antibodies bind to pro IL-1β, and the donor-acceptor proximity enables a fluorescent TR-FRET signal. The intensity of the signal is directly proportional to the concentration of pro IL-1β present in the cell lysate sample.
The HTRF pro IL-1β assay can be run in a 96- or 384-well low volume white detection plate (20 µL final). As described here, samples (cell lysates) or standards are dispensed directly into the assay plate for the detection of pro IL-1β by HTRF reagents. The antibodies labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.
| Sample size | 16 µL |
|---|---|
| Final assay volume | 20 µL |
| Kit component | Lyophilized standard, frozen detection antibodies & buffers |
| LOD & LOQ (in lysis buffer) | 38.5 & 130 pg/mL |
| Range | 312.5 – 20000 pg/mL |
| Time to result | Overnight at RT |
| Lysis buffer compatibility | LB#1 & LB#4 |
| Species | Human, not tested on mouse samples |
All of the 3 samples wwere measured 24 times, and the % CV was calculated for each. The samples were cell lysates from LPS stimulated THP-1.
| Sample | Mean [pro IL-1b] (pg/mL) | CV |
|---|---|---|
| 1 | 333 | 7% |
| 3 | 3728 | 2% |
| 4 | 8626 | 2% |
| Mean CV | 3% |
All of the samples wwere measured in 3 independent experiments (3 days), and the % CV was calculated for each. The samples were cell lysates from LPS stimulated THP-1.
| Sample | Mean [pro IL-1b] (pg/mL) | CV |
|---|---|---|
| 1 | 490 | 7 % |
| 3 | 4321 | 7 % |
| 5 | 17808 | 5 % |
| Mean CV | 6% |
The samples were LPS stimulated THP1 cell lysate serially diluted in LB#1. The excellent % of recovery obtained from these experiments shows the good dilution linearity of the assay.
| Dilution Factor (x) | Expected pro-IL1b concentration (pg/mL) |
Measured pro-IL1b concentration (pg/mL) |
% dilution recovery (%) |
|---|---|---|---|
| Neat | 16004 | 16004 | 100% |
| 2 | 8002 | 8429 | 105% |
| 4 | 4001 | 4205 | 105% |
| 8 | 2001 | 2082 | 104% |
| 16 | 1000 | 1035 | 103% |
| 32 | 500 | 471 | 94% |
| Mean CV | 102% | ||
Two known amounts of recombinant pro IL1 beta were spiked into a dilution of native sample from THP1 cell lysates stimulated with LPS. The expected concentrations were compared to those measured, in order to compute antigen recoveries (acceptance criteria: 80-120%). A 100% of recovery indicates similar measurements of cytokine from a sample and the kit standard.
| [pro IL1b] Standard (pg/mL) |
[pro IL1b] Native (pg/mL) |
Expected (pg/mL) | Obtained (pg/mL) | Recovery |
|---|---|---|---|---|
| 3264 | 5600 | 4432 | 5189 | 117% |
| 10083 | 6674 | 7467 | 112% | |
| 8664 | 10083 | 9373 | 10795 | 115% |
| 18541 | 13602 | 15280 | 112% | |
| Mean CV | 114% | |||
THP1 cells were plated at 25, 50,100, and 200 kcells/well and were stimulated for 3h with LPS at 1 µg/mL. After treatment, the medium was removed and cells were lysed with 40µL lysis buffer #1 for 30 minutes under gentle shaking. Then 16 µL of cell lysates were transferred into a white detection plate (384 low volume) to be analyzed with the human pro IL-1β assay.
THP1 cells were seeded in a 96-well culture plate (100,000 cells) and were treated with 1µg/mL LPS for 3 hours. Cells were then treated with increasing concentrations of Nigericin for 2 hours. After treatment, the medium was collected, and cells were lysed with 40µL lysis buffer #1 for 30 minutes under gentle shaking. Next, the cell lysates were tested using the HTRF pro IL-1β kit and the medium was tested using the HTRF IL-1β high performance detection kit (part 62HIL1B2PEG).
As expected, Nigerinicin induced the cleavage of pro IL-1β in LPS stimulated THP1 cells and the secretion of IL-1β in cell medium.
THP1 cells were seeded in a 96-well culture plate (100,000 cells) and were treated with 1µg/mL LPS for 3 hours. Cells were then treated with 12.5µM of Nigericin for 15 to 120 minutes. After treatment, the medium was collected, and cells were lysed with 40µL lysis buffer #1 for 30 minutes under gentle shaking. Next, the cell lysates were tested using the HTRF pro IL-1β kit and the medium was tested using the HTRF IL-1β high performance detection kit (part 62HIL1B2PEG).
| Application |
Protein Quantification
|
|---|---|
| Brand |
HTRF
|
| Cellular or Signaling Pathway |
Inflammasome/Pattern Recognition Receptors (PRRs)
|
| Detection Modality |
HTRF
|
| Dynamic Range |
312.5 - 20,000 pg/mL
|
| Limit of Detection |
38.5 pg/mL
|
| Limit of Quantification |
130 pg/mL
|
| Product Group |
Kit
|
| Sample Volume |
16 µL
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Target |
pro-IL1β
|
| Target Class |
Cytokines
|
| Target Species |
Human
|
| Technology |
TR-FRET
|
| Therapeutic Area |
Autoimmunity
Cardiovascular
Immuno-oncology
Infectious Diseases
Inflammation
Neuroscience
Oncology
Virology
|
| Unit Size |
10,000 assay points
|
Are you looking for resources, click on the resource type to explore further.
Loading...
We are here to answer your questions.